Livara Health, a value-based musculoskeletal (MSK) management leader, announced that it has raised $15 million in Series B funding. The round was led by A1 Health Ventures and it included existing investors Polaris Partners, Providence Ventures, Martin Ventures, and a new strategic investor.
A centralized musculoskeletal care plan is necessary to enhance patient outcomes, reduce overall care costs, ensure equitable access to care, and optimize resource utilization and risk stratification.
This new funding round will speed up the innovation of Livara’s technology and clinical capabilities to meet the needs and potential of this transformative care delivery model.
Livara has treated 120,000+ people since its founding and entered this year with nearly 4 million people eligible to access its MSK management platform through health plan and provider partnerships, including Medicare and commercially insured populations. Livara looks to grow all populations and manage additional risk for its partners, including assuming the total cost of musculoskeletal care.
Through a fully integrated suite of solutions, Livara helps payors reduce unnecessary utilization, providers better manage complex MSK populations, and patients get the care they need when and where required.
KEY QUOTES:
“At Livara, we are building a better musculoskeletal management solution, taking a biopsychosocial approach to patient care. Having treated patients for over 15 years through both virtual and in-person care pathways, we understand that delivering genuine patient-centered care requires a deep clinical program that can only be built through experience. This new round of funding will help us expand our already proven healthier standard of care for musculoskeletal patients and broaden our proprietary care delivery model focused on ensuring appropriate care pathways for all patients.”
– Rob Cohen, Chief Executive Officer of Livara Health
“Livara is tackling one of healthcare’s most significant challenges with the potential to improve the experience, health and wellbeing of anyone who faces challenges in their orthopedic care. We believe their virtual and in-person care delivery and care navigation solutions will have an enormous impact on the state of musculoskeletal care in the U.S. and we are thrilled to partner on actualizing this exciting vision.”
– Jon Phillips, Managing Director of A1 Health Ventures
